Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Blood Loss Massive
Total 0 results
Nothing found
Sponsors and Collaborators
Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
Jadran Galenski laboratorij d.d.Rijeka
Tianjin Medical University
Medical School University of Zagreb
ViiV Healthcare Australia Pty. Ltd
Uzès hospital
Diabetech
First Hospital Affiliated to Baotou Medical College, Baotou, China
Etablissement Publique de Santé Mentale de la Réunion
Pyrotech Therapeutics, Inc.
Vaxxinity, Inc.
CK-CARE (Christine Kühne - Center for Allergy Research and Education)
PharmTest s.r.o.
St. Louis Children's Hospital
Centre de Pharmacologie Clinique, INSERM CIC 501
Medtronic Poland Spółka z ograniczoną odpowiedzialnością
MRC/UVRI & LSHTM Uganda Research Unit
Marta Camats Terre
Ministry of Tourism, Sport and the Arts, British Columbia
Incept BioSystems, Inc.
View Full List
Medical Conditions
Well-trained Athletes
Post-Cerebrovascular Accident (CVA) Hemiparesis
Neoplasms, Advanced Solid
Vasomotor Symptoms Associated With Menopause
Nonarthritic Hip Disease
Fenofibrate
Relapsed Malignant Solid Tumor
Human Papilloma Virus Infection
Central Centrifugal Cicatricial Alopecia (CCCA)
Critical Illness Sepsis, Severe
Vomit
Native and Valve in Valve Aortic Valve Failure
Pulpotomy of Young Permanent Molars
High Turnover Bone Disease
Hepatitis C, Treatment Naïve, Genotype 1 Patients
Oral Allergic Syndrome
Non-sedentary
Family Functioning
Breast Cancer Treatment
Repository Corticotropin Injection
View Full List
Drug Interventions
40 consecutive doses of SUF NT 15 mcg taken every 20 minutes
Tamsulosin
0.45% saline in 5% dextrose (intravenous)
Durvalumab
Weak steroid (Flurolon, Allergan)
SHR-1210
RoActemra sc
Ropivacaine 0.2%
Lidocaine
Prazosin
ASP2151
Sulfasalazine
Keytruda
Oxaliplatin
Olorofim
SPLA2 Inhibitor
Phenelzine Sulfate
Famciclovir
Carboplatin
Experimental DW224aa
View Full List
CROs by country
Contract Research Organizations in Bangladesh
Contract Research Organizations in Benin
Contract Research Organizations in Ghana
Contract Research Organizations in Greece
Contract Research Organizations in India
Contract Research Organizations in Italy
Contract Research Organizations in Jordan
Contract Research Organizations in Mauritius
Contract Research Organizations in Moldova
Contract Research Organizations in Mongolia
Contract Research Organizations in Singapore
Contract Research Organizations in Uganda
Contract Research Organizations in Ukraine
CRO list by country
CROs in Bahrain
SGS
All CROs in Bahrain
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe